1. Offices of Pediatric Therapeutics, and
2. Policy and Planning, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland;
3. Office of Surveillance and Epidemiology, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland;
4. United States Public Health Service; and
5. Duke Clinical Research Institute, Duke University, Durham, North Carolina